Sfoglia per AUTORE
RICARDI U
Collezione AOU Novara

  

Items : 8

Role of Rituximab Addition to First-line Chemotherapy Regimens in Nodular Lymphocyte-predominant Hodgkin Lymphoma: A Study by Fondazione Italiana Linfomi. in HemaSphere / Hemasphere. 2023 Apr 4;7(4):e837. doi: 10.1097/HS9.0000000000000837. eCollection 2023 Apr.

2023
AOU Città della Salute di Torino
AOU Novara

Ferretti VV; Ricardi U; Arcaini L; Ferrari S; Lazic T; Cristinelli C; Gotti M; Sciarra R; Pulsoni A; Merli F; Luminari S; Zerbi C; Trentin L; Pagani C; Dalceggio D; Pravato S; Visentin A; Alvarez I; Del Giudice I; D'Elia GM; Zoboli V; Annechini G; Tartaglia G; Bonfichi M; Filippi AR; Fabbri A; Liberati AM; Merli M; Nassi L; et alii...

Immunotherapy in association with stereotactic radiotherapy for non-small cell lung cancer brain metastases: results from a multicentric retrospective study on behalf of AIRO. in Neuro-oncology / Neuro Oncol. 2021 Oct 1;23(10):1750-1764. doi: 10.1093/neuonc/noab129.

2021
AO Cuneo
AOU Novara

Livi L; Navarria P; Ricardi U; Scotti V; Fariselli L; Muto P; Maranzano E; Pecchioli G; Desideri I; Giaj-Levra N; Pedretti S; Krengli M; Trignani M; Merlotti A; Giudice E; Ciammella P; Bruni A; Pasqualetti F; Tini P; Mantovani C; Beltramo G; Franceschini D; Matteucci P; Anselmo P; Di Franco R; Caini S; Pinzi V; Osti MF; Olmetto E; et alii...

Role of radiotherapy to bulky sites of advanced Hodgkin lymphoma treated with ABVD: final results of FIL HD0801 trial. in Blood advances / Blood Adv. 2021 Nov 9;5(21):4504-4514. doi: 10.1182/bloodadvances.2021005150.

2021
ASL Torino 4
AOU Città della Salute di Torino
AOU Novara

Filippi AR; Freilone R; Ciccone G; Rota-Scalabrini D; Zilioli VR; Botto B; Abruzzese E; Zaja F; Tani M; Rigacci L; Santoro A; Simontacchi G; Grapulin L; Pulsoni A; Zanni M; Franzone P; Nassi L; Frezza GP; Nardella A; Re A; Buglione M; Pavone V; Gioia DM; Sacchetti GM; Gotti M; Evangelista A; Levis M; Ricardi U; Zinzani PL; et alii...

Automatic genetic planning for volumetric modulated arc therapy: A large multi-centre validation for prostate cancer. in Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology / Radiother Oncol. 2020 Jul;148:126-132. doi: 10.1016/j.radonc.2020.04.020. Epub 2020 Apr 21.

2020
AO Ordine Mauriziano
AOU Città della Salute di Torino
AOU Novara

Ciscognetti N; Rumeileh IA; Reccanello S; Romeo A; Savini A; Strolin S; Strigari L; Borzillo V; Ametrano G; Zerini D; Comi S; Tini P; Marco Deotto G; Ruo Redda MG; Gino E; Pisani C; Loi G; Vecchi C; Sardo A; Bartoncini S; Zara S; Alparone A; Rossi L; Fiandra C; Guerrisi F; Balestra G; Ricardi U; Heijmen B;

Hypofractionated radiation therapy versus chemotherapy with temozolomide in patients affected by RPA class V and VI glioblastoma: a randomized phase II trial. in Journal of neuro-oncology / J Neurooncol. 2019 Jul;143(3):447-455. doi: 10.1007/s11060-019-03175-2. Epub 2019 May 4.

2019
AOU Città della Salute di Torino
AOU Novara

Ricardi U; Bruni A; Scoccianti S; Fusco V; Gatta R; Riva N; Pegurri L; Borghetti P; Pirtoli L; Meduri B; Krengli M; Triggiani L; Turco E; Masini L; Pedretti S; Santoni R; Magrini SM; Buglione M;

Prevalence of Cardiovascular Disease and Osteoporosis During Androgen Deprivation Therapy Prescription Discordant to EAU Guidelines: Results From a Multicenter, Cross-sectional Analysis From the CHOsIng Treatment for Prostate canCEr (CHOICE) Study. in Urology / Urology. 2016 Oct;96:165-170. doi: 10.1016/j.urology.2016.06.024. Epub 2016 Jul 8.

2016
AOU Città della Salute di Torino
AOU Novara

Savoca G; Gontero P; Mantini G; Siracusano S; Corvò R; Tenaglia R; De Paula U; Pinnarò P; Leonardi R; Carmignani G; Novella G; Brausi M; Simeone C; Vespasiani G; Ludovico G; Terrone C; Pagliarulo A; Rocco F; Ricardi U; Lay G; Del Nero A; Serni S; Mirone V; Zattoni F; Porena M; Gabriele P; Trippa F; Randone D; Bortolus R; et alii...

Patterns of prescription and adherence to European Association of Urology guidelines on androgen deprivation therapy in prostate cancer: an Italian multicentre cross-sectional analysis from the Choosing Treatment for Prostate Cancer (CHOICE) study. in BJU international / BJU Int. 2016 Jun;117(6):867-73. doi: 10.1111/bju.13307. Epub 2015 Sep 23.

2016
AOU Città della Salute di Torino
AOU Novara

Ficarra V; Savoca G; Gontero P; Mantini G; Tenaglia R; Siracusano S; Corvò R; De Paula U; Leonardi R; Pinnarò P; Carmignani G; Simeone C; Novella G; Brausi M; Vespasiani G; Ludovico G; Terrone C; Pagliarulo A; Rocco F; Ricardi U; Lay G; Del Nero A; Serni S; Mirone V; Porena M; Zattoni F; Trippa F; Gabriele P; Randone D; et alii...

Interim Positron Emission Tomography Response-Adapted Therapy in Advanced-Stage Hodgkin Lymphoma: Final Results of the Phase II Part of the HD0801 Study. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2016 Apr 20;34(12):1376-85. doi: 10.1200/JCO.2015.63.0699. Epub 2016 Feb 16.

2016
ASL Torino 4
AOU Città della Salute di Torino
AOU Novara

Levis A; Argnani L; Sacchetti GM; Borsatti E; Pregno P; Freilone R; Tani M; Rusconi C; Salvi F; Stelitano C; Gaidano G; Rigacci L; Pulsoni A; Pavone V; Vitolo U; Zaja F; Anastasia A; Rossi G; Brusamolino E; Bonfichi M; Ricardi U; Santoro A; Evangelista A; Ciccone G; Castagnoli A; Gioia DM; Broccoli A; Zinzani PL;